Almost 96% of patients with High-Grade Serous Ovarian Cancer (HGSOC) carry TP53 mutations, and less than 15% of these survive 10 years post initial diagnosis [2]. This evidence concerns the gene TP53 and ovarian serous adenocarcinoma.